Merle Fernandes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Merle Fernandes has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Savitri Sharma
Jhaveri Microbiology Centre, LV Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad, India
6 shared publicationsAntonio Di Zazzo
LVPEI, Hyderabad, Telangana, India
5 shared publicationsNitin Mohan
Ocular Microbiology Service, L.V. Prasad Eye Institute, Visakhapatnam, Andhra Pradesh, India
5 shared publicationsAravind Roy
The Cornea Institute, Vijayawada, India
3 shared publicationsBhagyasree Msc Madduri
Ocular Microbiology Service, LV Prasad Eye Institute, GMR Varalakshmi Campus, Visakhapatnam, India
3 shared publicationsDivya Vira
Cornea and Anterior Segment Services, L. V. Prasad Eye Institute, Visakhapatnam, Andhra Pradesh, 530040, India
3 shared publications
Latest Publications
- 9 December 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (11) , 1306-1311
Efficacy of natamycin monotherapy versus combination therapy with voriconazole for fungal keratitis: a randomised clinical trial
Background: To assess whether adjunctive topical voriconazole 1% offers additional benefit over natamycin 5% monotherapy in fungal keratitis, focusing on ulcer resolution, visual outcomes and safety. Methods: This prospective, double-masked, randomised clinical trial was conducted at L.V. Prasad Eye Institute, India. A total of 108 adults with smear- or culture-positive fungal keratitis were randomised 1:1 to receive either natamycin 5% plus voriconazole 1% (combination therapy) or natamycin 5% plus placebo (monotherapy). Drops were instilled hourly for 72 hours, then tapered over 2 weeks. All patients also received oral ketoconazole and cycloplegics. The primary outcome was complete ulcer resolution with medical therapy alone, defined as epithelial closure with scarring without therapeutic penetrating keratoplasty. Secondary outcomes included time to epithelial healing, best-corrected visual acuity (BCVA) and adverse events. Results: Of 94 eyes completing follow-up (mean (SD) age, 50.4 (12.4) years; 66 (70%) male), complete healing occurred in 38 of 48 eyes (79.2%) in the combination group and 35 of 46 eyes (76.1%) in the monotherapy group (absolute difference, 3.1%; 95% CI −13.2% to 19.4%; p=0.70). Median time to epithelial healing was 38 days (IQR, 20–60) for combination therapy and 39 days (IQR, 21–61) for monotherapy (p=0.86). Final mean BCVA was 0.43 logMAR (logarithm of the minimum angle of resolution) versus 0.58 logMAR, respectively (p=0.07). In non- Aspergillus cases, natamycin monotherapy yielded better visual outcomes (p=0.048). Conclusions: Adjunctive topical voriconazole did not significantly improve clinical outcomes compared with natamycin monotherapy. Natamycin 5% remains an effective first-line treatment, particularly in non- Aspergillus keratitis. Further studies are warranted to explore targeted roles for combination therapy. Trial registration number: NCT03230058 .
- 9 December 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (11) , 1306-1311
Efficacy of natamycin monotherapy versus combination therapy with voriconazole for fungal keratitis: a randomised clinical trial
Background: To assess whether adjunctive topical voriconazole 1% offers additional benefit over natamycin 5% monotherapy in fungal keratitis, focusing on ulcer resolution, visual outcomes and safety. Methods: This prospective, double-masked, randomised clinical trial was conducted at L.V. Prasad Eye Institute, India. A total of 108 adults with smear- or culture-positive fungal keratitis were randomised 1:1 to receive either natamycin 5% plus voriconazole 1% (combination therapy) or natamycin 5% plus placebo (monotherapy). Drops were instilled hourly for 72 hours, then tapered over 2 weeks. All patients also received oral ketoconazole and cycloplegics. The primary outcome was complete ulcer resolution with medical therapy alone, defined as epithelial closure with scarring without therapeutic penetrating keratoplasty. Secondary outcomes included time to epithelial healing, best-corrected visual acuity (BCVA) and adverse events. Results: Of 94 eyes completing follow-up (mean (SD) age, 50.4 (12.4) years; 66 (70%) male), complete healing occurred in 38 of 48 eyes (79.2%) in the combination group and 35 of 46 eyes (76.1%) in the monotherapy group (absolute difference, 3.1%; 95% CI −13.2% to 19.4%; p=0.70). Median time to epithelial healing was 38 days (IQR, 20–60) for combination therapy and 39 days (IQR, 21–61) for monotherapy (p=0.86). Final mean BCVA was 0.43 logMAR (logarithm of the minimum angle of resolution) versus 0.58 logMAR, respectively (p=0.07). In non- Aspergillus cases, natamycin monotherapy yielded better visual outcomes (p=0.048). Conclusions: Adjunctive topical voriconazole did not significantly improve clinical outcomes compared with natamycin monotherapy. Natamycin 5% remains an effective first-line treatment, particularly in non- Aspergillus keratitis. Further studies are warranted to explore targeted roles for combination therapy. Trial registration number: NCT03230058 .
- 24 September 2025
- Published by Springer Nature in Eye
- Vol. 39 (16) , 2846-2851
Sustainable ophthalmology: an overview of concepts and practices
Climate change and global warming are significant global challenges, with healthcare systems contributing substantially to greenhouse gas (GHG) emissions. (1) This review examines the environmental impact of ophthalmic care, focusing on energy consumption, surgical waste, single-use supplies, and patient travel. Strategies to reduce the carbon footprint include adopting telemedicine, digital records, energy-efficient infrastructure, and sustainable surgical practices like reusing instruments, recycling, and minimising waste. Decentralising eye care and increasing the proximity of services to people and the community, for example, doorstep healthcare, can further lower travel-related emissions. Sustainability also aligns with financial efficiency, particularly in resource-limited settings where affordability is critical. Collaborative efforts among policymakers, industry, and clinicians are vital to fostering environmentally conscious ophthalmic care. This article highlights actionable strategies to integrate environmental responsibility into ophthalmology, balancing quality care, cost efficiency, and sustainability for a greener future in healthcare.
- 24 September 2025
- Published by Springer Nature in Eye
- Vol. 39 (16) , 2846-2851
Sustainable ophthalmology: an overview of concepts and practices
Climate change and global warming are significant global challenges, with healthcare systems contributing substantially to greenhouse gas (GHG) emissions. (1) This review examines the environmental impact of ophthalmic care, focusing on energy consumption, surgical waste, single-use supplies, and patient travel. Strategies to reduce the carbon footprint include adopting telemedicine, digital records, energy-efficient infrastructure, and sustainable surgical practices like reusing instruments, recycling, and minimising waste. Decentralising eye care and increasing the proximity of services to people and the community, for example, doorstep healthcare, can further lower travel-related emissions. Sustainability also aligns with financial efficiency, particularly in resource-limited settings where affordability is critical. Collaborative efforts among policymakers, industry, and clinicians are vital to fostering environmentally conscious ophthalmic care. This article highlights actionable strategies to integrate environmental responsibility into ophthalmology, balancing quality care, cost efficiency, and sustainability for a greener future in healthcare.
- Open Access
- 1 December 2024
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 50 (12) , 1208-1214
Effect of digital cataract workflow on time and resource efficiencies in cataract surgery: time and motion study
Purpose: To compare time and resource saving with integration of digital cataract workflow to the existing workflow in high-volume cataract surgery clinics. Setting: L V Prasad Eye Institute, Hyderabad, India (site 1), and Narayana Nethralaya, Bengaluru, India (site 2). Design: Prospective, time and motion. Methods: The total time to complete each step (preoperative measurements, surgical planning, and surgical procedures) of the cataract workflow, number of data fields entered, and support staff required for both workflows were recorded. All study measurements were determined first for existing electronic medical record (EMR) cataract workflow followed by digital workflow (integrated data management system with data reviewer, surgical planner, and data transfer to operating room) at both sites. Results: A total of 85 (site 1, 44; site 2, 41) cataract workflows were analyzed. The integration of digital workflow into the site's existing EMR workflow reduced the mean time for preoperative measurements by 25.3% (P = .006), surgical planning by 55.1% (P = .008), and surgical procedures by 22.6% (P = .002). The mean ± SD overall time for the surgery was significantly shorter in the digital group (887.3 ± 103.3 vs 1271.3 ± 300.7 seconds; P < .0001). For both sites, the number of data fields recorded and number of support staff needed were significantly lesser for the digital workflow (P < .0001, for both). Conclusions: Integration of digital workflow significantly reduced the overall cataract surgery time, variability of overall time, number of data fields recorded, and resource utilization. Complete digitalization has important implications for improving the efficiency and standardization of cataract surgery workflow.
- 1 December 2024
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 50 (12) , 1208-1214
Open AccessEffect of digital cataract workflow on time and resource efficiencies in cataract surgery: time and motion study
Purpose: To compare time and resource saving with integration of digital cataract workflow to the existing workflow in high-volume cataract surgery clinics. Setting: L V Prasad Eye Institute, Hyderabad, India (site 1), and Narayana Nethralaya, Bengaluru, India (site 2). Design: Prospective, time and motion. Methods: The total time to complete each step (preoperative measurements, surgical planning, and surgical procedures) of the cataract workflow, number of data fields entered, and support staff required for both workflows were recorded. All study measurements were determined first for existing electronic medical record (EMR) cataract workflow followed by digital workflow (integrated data management system with data reviewer, surgical planner, and data transfer to operating room) at both sites. Results: A total of 85 (site 1, 44; site 2, 41) cataract workflows were analyzed. The integration of digital workflow into the site's existing EMR workflow reduced the mean time for preoperative measurements by 25.3% (P = .006), surgical planning by 55.1% (P = .008), and surgical procedures by 22.6% (P = .002). The mean ± SD overall time for the surgery was significantly shorter in the digital group (887.3 ± 103.3 vs 1271.3 ± 300.7 seconds; P < .0001). For both sites, the number of data fields recorded and number of support staff needed were significantly lesser for the digital workflow (P < .0001, for both). Conclusions: Integration of digital workflow significantly reduced the overall cataract surgery time, variability of overall time, number of data fields recorded, and resource utilization. Complete digitalization has important implications for improving the efficiency and standardization of cataract surgery workflow.
- Open Access
- 20 October 2023
- Published by Medknow in Taiwan Journal of Ophthalmology
- Vol. 13 (4) , 434-442
Peters anomaly: An overview
Peters anomaly (PA) is a rare, often bilateral, congenital corneal opacity, usually with a sporadic inheritance pattern, characterized by corneal opacities and irido-corneal or lenticular-corneal adhesions with a defect in the Descemet’s membrane, occurring due to anterior segment dysgenesis during fetal development. Due to other ocular and systemic comorbidities, a team comprising pediatric cornea, glaucoma, and strabismus specialists in addition to a pediatrician and geneticist is necessary for the appropriate management of these children. Since the outcome of pediatric penetrating keratoplasty is variable and has a higher chance of failure when accompanied by additional procedures, such as lensectomy and vitrectomy, minimally invasive alternatives are increasingly being offered to these patients. Of note is the recently reported novel procedure: selective endothelialectomy for PA, which avoids the need for a corneal transplant and results in gradual clearing of the corneal opacity over time. In this overview, we aimed to describe the etiology, classification, pathophysiology, histopathology, clinical features, and management of PA.
- 20 October 2023
- Published by Medknow in Taiwan Journal of Ophthalmology
- Vol. 13 (4) , 434-442
Open AccessPeters anomaly: An overview
Peters anomaly (PA) is a rare, often bilateral, congenital corneal opacity, usually with a sporadic inheritance pattern, characterized by corneal opacities and irido-corneal or lenticular-corneal adhesions with a defect in the Descemet’s membrane, occurring due to anterior segment dysgenesis during fetal development. Due to other ocular and systemic comorbidities, a team comprising pediatric cornea, glaucoma, and strabismus specialists in addition to a pediatrician and geneticist is necessary for the appropriate management of these children. Since the outcome of pediatric penetrating keratoplasty is variable and has a higher chance of failure when accompanied by additional procedures, such as lensectomy and vitrectomy, minimally invasive alternatives are increasingly being offered to these patients. Of note is the recently reported novel procedure: selective endothelialectomy for PA, which avoids the need for a corneal transplant and results in gradual clearing of the corneal opacity over time. In this overview, we aimed to describe the etiology, classification, pathophysiology, histopathology, clinical features, and management of PA.
- 16 December 2022
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 44 (5) , 509-511
Progeroid syndrome of De Barsy – a case report and review of ophthalmic literature
Background: This report describes a very rare case of progeroid syndrome of De Barsy (Cutis laxa-corneal clouding syndrome). Materials and Methods: A 2 year-old child presented to the pediatric ophthalmology outpatients with bilateral congenital corneal opacification along with dysmorphic facial features, including loose wrinkled skin, progeroid appearance, delayed milestones, short stature, multiple hyper-extensible joints, muscular hypotonia, pectus excavatum and congenital dislocation of the hip joint. The child underwent a detailed ophthalmic work up and systemic evaluation by a clinical geneticist. Results: Ophthalmic management in the form of bilateral sequential penetrating keratoplasties and a left eye trabeculectomy for medically uncontrolled angle-closure glaucoma was performed. Visual rehabilitation with glasses and amblyopia therapy is ongoing. Histopathology of the corneal button revealed loss of the bowman’s layer which was replaced by a fibrous pannus while the stroma showed loss of stromal lamellar architecture with anterior and mid stroma showing vascularization. Genetic testing confirmed a mutation in the PYCR1 gene for a homozygous autosomal recessive cutis laxa type IIB. Conclusions: Although rare, De Barsy syndrome is an important cause of corneal opacification at birth with multiple systemic abnormalities that requires intervention.
- 16 December 2022
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 44 (5) , 509-511
Progeroid syndrome of De Barsy – a case report and review of ophthalmic literature
Background: This report describes a very rare case of progeroid syndrome of De Barsy (Cutis laxa-corneal clouding syndrome). Materials and Methods: A 2 year-old child presented to the pediatric ophthalmology outpatients with bilateral congenital corneal opacification along with dysmorphic facial features, including loose wrinkled skin, progeroid appearance, delayed milestones, short stature, multiple hyper-extensible joints, muscular hypotonia, pectus excavatum and congenital dislocation of the hip joint. The child underwent a detailed ophthalmic work up and systemic evaluation by a clinical geneticist. Results: Ophthalmic management in the form of bilateral sequential penetrating keratoplasties and a left eye trabeculectomy for medically uncontrolled angle-closure glaucoma was performed. Visual rehabilitation with glasses and amblyopia therapy is ongoing. Histopathology of the corneal button revealed loss of the bowman’s layer which was replaced by a fibrous pannus while the stroma showed loss of stromal lamellar architecture with anterior and mid stroma showing vascularization. Genetic testing confirmed a mutation in the PYCR1 gene for a homozygous autosomal recessive cutis laxa type IIB. Conclusions: Although rare, De Barsy syndrome is an important cause of corneal opacification at birth with multiple systemic abnormalities that requires intervention.
- 3 November 2022
- Published by Elsevier in Experimental Eye Research
- Vol. 225, 109301
Tissue remodeling in adult vernal keratoconjunctivitis
- 3 November 2022
- Published by Elsevier in Experimental Eye Research
- Vol. 225, 109301
Tissue remodeling in adult vernal keratoconjunctivitis
- 22 October 2022
- Published by Springer Nature in International Ophthalmology
- Vol. 43 (5) , 1639-1645
Challenges in management of microbial keratitis during COVID-19 pandemic related lockdown: a comparative analysis with pre pandemic data
Purpose To study the challenges of managing microbial keratitis(MK) during the COVID19 pandemic related lockdown and assess the outcomes of treatment at a tertiary cornea service. Methods Retrospective, non comparative study of electronic medical records of MK presenting to a network of four tertiary care cornea services. The medical history, presenting clinical features, microbiology work up and treatment outcomes were analyzed. The primary outcome measure was final outcome at last follow up. Secondary outcomes measures were non-compliance to treatment due to travel restrictions, therapeutic PKP not done due non availability of corneal tissues. Results- MK was noted in 330 eyes of 330 patients between April and May 2020. Of these 237(71.8%) were males. Median age was 45 years(IQR, 33-56). Low socioeconomic status noted in 102(30.9%). Patients travelling beyond the district from where the hospital was located comprised of 64.9%(n=214). At a median follow up of 32 days(IQR, 9-54), 118(35.8%) patients had resolved, with medical management, 73(22.1%) patients were under active treatment, 139(42.1%) were lost to follow up. Sixty-six patients(20%) were non-compliant to treatment of which 59 could not follow appointment schedule due to travel restrictions. Therapeutic PKP (TPK) was planned in 48/128 (37.5%) patients, but was performed in only 34/48 (70.8%) due to non-availability of donor corneas. Conclusions Abnormal social circumstances due to the COVID pandemic and the ensuing impediments to travel for access to health care affected compliance to treatment of ocular emergencies such as microbial keratitis.
- 22 October 2022
- Published by Springer Nature in International Ophthalmology
- Vol. 43 (5) , 1639-1645
Challenges in management of microbial keratitis during COVID-19 pandemic related lockdown: a comparative analysis with pre pandemic data
Purpose To study the challenges of managing microbial keratitis(MK) during the COVID19 pandemic related lockdown and assess the outcomes of treatment at a tertiary cornea service. Methods Retrospective, non comparative study of electronic medical records of MK presenting to a network of four tertiary care cornea services. The medical history, presenting clinical features, microbiology work up and treatment outcomes were analyzed. The primary outcome measure was final outcome at last follow up. Secondary outcomes measures were non-compliance to treatment due to travel restrictions, therapeutic PKP not done due non availability of corneal tissues. Results- MK was noted in 330 eyes of 330 patients between April and May 2020. Of these 237(71.8%) were males. Median age was 45 years(IQR, 33-56). Low socioeconomic status noted in 102(30.9%). Patients travelling beyond the district from where the hospital was located comprised of 64.9%(n=214). At a median follow up of 32 days(IQR, 9-54), 118(35.8%) patients had resolved, with medical management, 73(22.1%) patients were under active treatment, 139(42.1%) were lost to follow up. Sixty-six patients(20%) were non-compliant to treatment of which 59 could not follow appointment schedule due to travel restrictions. Therapeutic PKP (TPK) was planned in 48/128 (37.5%) patients, but was performed in only 34/48 (70.8%) due to non-availability of donor corneas. Conclusions Abnormal social circumstances due to the COVID pandemic and the ensuing impediments to travel for access to health care affected compliance to treatment of ocular emergencies such as microbial keratitis.
- 12 May 2022
- Published by Wolters Kluwer Health in Cornea
- Vol. 41 (9) , 1110-1115
Enterobacter cloacae Keratitis: Clinicomicrobiological Profiles, Risk Factors, and Outcomes
Purpose: The purpose of the study was to report the clinical features, risk factors, antibiotic susceptibility, and treatment outcomes in a series of Enterobacter cloacae keratitis. Methods: A retrospective analysis was performed of the electronic medical records of microbial keratitis caused by E. cloacae identified by the Vitek 2 system (BioMerieux, Craponne, France). We collected data pertaining to demographics, risk factors, ulcer characteristics, antibiogram, visual acuity at presentation and final follow-up, and management outcome. The main outcome measure was resolution of infection. The final visual acuity was the secondary outcome measure. Results: Ten episodes of E. cloacae keratitis in 9 patients were identified between January 2009 and December 2019. Nine (90%) cases had undergone penetrating keratoplasty and 8 were failed grafts. Other risk factors included topical steroid use and irregular ocular surface due to epithelial bullae. The mean ulcer size was 17.55 ± 13.99 mm2. More than 80% of isolates were sensitive to chloramphenicol, gentamicin, and colistin. Nine (90%) cases healed on medical management within 56.55 ± 26.74 days (range 9–120 d), although almost all required adjunctive procedures: tissue adhesive application (n = 6) and/or tarsorrhaphy (n = 4). One case with a near total infiltrate had a mixed infection with Kocuria kristinae requiring therapeutic penetrating keratoplasty. One case developed endophthalmitis and phthisis after the corneal infiltrate resolved. Conclusions: E. cloacae keratitis is a rare clinical entity seen more often in immunocompromised host conditions such as failed corneal transplants with concomitant topical steroids. Most cases healed with medical management.
- 12 May 2022
- Published by Wolters Kluwer Health in Cornea
- Vol. 41 (9) , 1110-1115
Enterobacter cloacae Keratitis: Clinicomicrobiological Profiles, Risk Factors, and Outcomes
Purpose: The purpose of the study was to report the clinical features, risk factors, antibiotic susceptibility, and treatment outcomes in a series of Enterobacter cloacae keratitis. Methods: A retrospective analysis was performed of the electronic medical records of microbial keratitis caused by E. cloacae identified by the Vitek 2 system (BioMerieux, Craponne, France). We collected data pertaining to demographics, risk factors, ulcer characteristics, antibiogram, visual acuity at presentation and final follow-up, and management outcome. The main outcome measure was resolution of infection. The final visual acuity was the secondary outcome measure. Results: Ten episodes of E. cloacae keratitis in 9 patients were identified between January 2009 and December 2019. Nine (90%) cases had undergone penetrating keratoplasty and 8 were failed grafts. Other risk factors included topical steroid use and irregular ocular surface due to epithelial bullae. The mean ulcer size was 17.55 ± 13.99 mm2. More than 80% of isolates were sensitive to chloramphenicol, gentamicin, and colistin. Nine (90%) cases healed on medical management within 56.55 ± 26.74 days (range 9–120 d), although almost all required adjunctive procedures: tissue adhesive application (n = 6) and/or tarsorrhaphy (n = 4). One case with a near total infiltrate had a mixed infection with Kocuria kristinae requiring therapeutic penetrating keratoplasty. One case developed endophthalmitis and phthisis after the corneal infiltrate resolved. Conclusions: E. cloacae keratitis is a rare clinical entity seen more often in immunocompromised host conditions such as failed corneal transplants with concomitant topical steroids. Most cases healed with medical management.
- Open Access
- 12 May 2022
- Published by Scientific Scholar in IHOPE Journal of Ophthalmology
- Vol. 1 (2) , 32-33
Eye care and the carbon foot print
- 12 May 2022
- Published by Scientific Scholar in IHOPE Journal of Ophthalmology
- Vol. 1 (2) , 32-33
Open AccessEye care and the carbon foot print
- 22 December 2021
- Published by Wolters Kluwer Health in Cornea
- Vol. 41 (9) , 1103-1109
Pediatric Microbial Keratitis: Identification of Clinical Biomarkers for Prognosis and Outcome of 218 Cases From 2009 to 2019
Purpose: The aim of this study was to analyze the risk factors, microbiological profile, and treatment efficacy in pediatric microbial keratitis (MK) and to identify clinical biomarkers prognosticating outcome. Methods: A retrospective analysis was conducted from patients younger than 16 years with MK-excluding viral, marginal, or interstitial keratitis. Data pertaining to predisposing factors, symptom duration, prior treatment, ulcer characteristics, microbiological profile, time to resolution, and final outcome were recorded. Statistical analysis was performed. The mixed-effects linear regression model with random intercept was used to evaluate factors affecting time to resolution. Results: Among 218 episodes of 215 pediatric patients with MK, the geometric mean of central [median 3 mm, interquartile range (IQR) 1–4.3 mm] and peripheral ulcers (median 1 mm, IQR 1–2.5 mm) was significantly different (P < 0.0001). Organisms identified were bacteria (56.9%), fungi (31.5%), and acanthamoebae (2.3%). Of 172 cases (78.8%), which resolved in a median resolution time of 22 days (IQR, 11–44 days), 107 (81.6%) with absent/negative microbiology healed on empirical therapy. On multivariate analysis, peripheral ulcers and geometric mean ulcer size affected time to resolution. Significantly higher percentage of eyes, which worsened or perforated, were on topical steroids compared with those which healed (31.8% vs. 9.2%, P = 0.0061). Conclusions: Good outcome even in culture negative cases suggests empirical therapy may be instituted for nonsevere peripheral pediatric MK; however, the importance of a microbiological workup cannot be underscored enough. Ulcer location and geometric mean size of ulcer may be used as clinical prognostic markers for resolution.
- 22 December 2021
- Published by Wolters Kluwer Health in Cornea
- Vol. 41 (9) , 1103-1109
Pediatric Microbial Keratitis: Identification of Clinical Biomarkers for Prognosis and Outcome of 218 Cases From 2009 to 2019
Purpose: The aim of this study was to analyze the risk factors, microbiological profile, and treatment efficacy in pediatric microbial keratitis (MK) and to identify clinical biomarkers prognosticating outcome. Methods: A retrospective analysis was conducted from patients younger than 16 years with MK-excluding viral, marginal, or interstitial keratitis. Data pertaining to predisposing factors, symptom duration, prior treatment, ulcer characteristics, microbiological profile, time to resolution, and final outcome were recorded. Statistical analysis was performed. The mixed-effects linear regression model with random intercept was used to evaluate factors affecting time to resolution. Results: Among 218 episodes of 215 pediatric patients with MK, the geometric mean of central [median 3 mm, interquartile range (IQR) 1–4.3 mm] and peripheral ulcers (median 1 mm, IQR 1–2.5 mm) was significantly different (P < 0.0001). Organisms identified were bacteria (56.9%), fungi (31.5%), and acanthamoebae (2.3%). Of 172 cases (78.8%), which resolved in a median resolution time of 22 days (IQR, 11–44 days), 107 (81.6%) with absent/negative microbiology healed on empirical therapy. On multivariate analysis, peripheral ulcers and geometric mean ulcer size affected time to resolution. Significantly higher percentage of eyes, which worsened or perforated, were on topical steroids compared with those which healed (31.8% vs. 9.2%, P = 0.0061). Conclusions: Good outcome even in culture negative cases suggests empirical therapy may be instituted for nonsevere peripheral pediatric MK; however, the importance of a microbiological workup cannot be underscored enough. Ulcer location and geometric mean size of ulcer may be used as clinical prognostic markers for resolution.